XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 20 search results for !padrenullquery UclSubject:"health" UclOrgUnit:"Made at UCL"

Results

  1. The tumour hunters: Precision targeting for prostate cancer | Made at …

    https://www.ucl.ac.uk/made-at-ucl/stories/tumour-hunters-precision-targeting-prostate-cancer

    3 Nov 2019: UCL researchers are transforming the treatment and diagnosis of prostate cancer. SmartTarget helps surgeons to better pinpoint prostate cancer in biopsies while MRI scanning, an alternative diagnosis method, is doubling cancer detection rates.

    UCL researchers are transforming the treatment and diagnosis of prostate cancer. SmartTarget helps surgeons to better pinpoint prostate cancer in biopsies while MRI scanning, an alternative diagnosis method, is doubling cancer detection rates.

  2. Antiretroviral treatment prevents sexual transmission of HIV | Made…

    https://www.ucl.ac.uk/made-at-ucl/stories/antiretroviral-treatment-prevents-sexual-transmission-hiv

    3 Nov 2019: People on HIV treatment 'ART', where the virus is at undetectable levels, are “sexually non-infectious”, finds a landmark study led by Prof Alison Rodger. This will have a strong impact on people with HIV and help address HIV-related stigma.

    People on HIV treatment 'ART', where the virus is at undetectable levels, are “sexually non-infectious”, finds a landmark study led by Prof Alison Rodger. This will have a strong impact on people with HIV and help address HIV-related stigma.

  3. Two people regain sight after pioneering eye therapy | Made at UCL -…

    https://www.ucl.ac.uk/made-at-ucl/stories/two-people-regain-sight-after-pioneering-eye-therapy

    2 Nov 2019: Making the blind see - last year two people, whose sight had deteriorated due to age-related macular degeneration (AMD), were able to see the world again, following ground-breaking stem cell-based therapy pioneered at UCL.

    Making the blind see - last year two people, whose sight had deteriorated due to age-related macular degeneration (AMD), were able to see the world again, following ground-breaking stem cell-based therapy pioneered at UCL.

  4. First UK surgery in womb for babies with spina bifida | Made at UCL - …

    https://www.ucl.ac.uk/made-at-ucl/stories/first-uk-surgery-womb-babies-spina-bifida

    1 Oct 2019: A team from University College London Hospitals (UCLH) and Great Ormond Street Hospital (GOSH) has operated on the abnormally developed spinal cords of two babies in the womb, in a UK medical first.

    A team from University College London Hospitals (UCLH) and Great Ormond Street Hospital (GOSH) has operated on the abnormally developed spinal cords of two babies in the womb, in a UK medical first.

  5. Single-dose technique transforms breast cancer treatment | Made at…

    https://www.ucl.ac.uk/made-at-ucl/stories/single-dose-technique-transforms-breast-cancer-treatment

    1 Oct 2019: Research at UCL has transformed the treatment of breast cancer, the most common cancer in women, using innovative one-off targeted intraoperative radiation therapy (TARGIT IORT). This new treatment avoids the burden of a three- to six-week course of

    Research at UCL has transformed the treatment of breast cancer, the most common cancer in women, using innovative one-off targeted intraoperative radiation therapy (TARGIT IORT). This new treatment avoids the burden of a three- to six-week course of postoperative radiotherapy.

  6. Silencing the Huntington's disease gene | Made at UCL - UCL -…

    https://www.ucl.ac.uk/made-at-ucl/stories/silencing-huntingtons-disease-gene

    26 Sep 2019: Professor Sarah Tabrizi, Director of the Huntington’s Disease Centre at the UCL Queen Square Institute of Neurology, is playing a leading role in the global push to find a cure for Huntington’s disease.

    Professor Sarah Tabrizi, Director of the Huntington’s Disease Centre at the UCL Queen Square Institute of Neurology, is playing a leading role in the global push to find a cure for Huntington’s disease.

  7. Creating a brighter future for the world’s poorest children | Made at …

    https://www.ucl.ac.uk/made-at-ucl/stories/creating-brighter-future-worlds-poorest-children

    23 Sep 2019: The Brain Imaging for Global Health (BRIGHT) Project is providing the first-ever brain imaging of infants in Africa to understand and lessen the impact of poverty and malnutrition on brain development.

    The Brain Imaging for Global Health (BRIGHT) Project is providing the first-ever brain imaging of infants in Africa to understand and lessen the impact of poverty and malnutrition on brain development.

  8. Woman with novel gene mutation lives almost pain-free | Made at UCL - …

    https://www.ucl.ac.uk/made-at-ucl/stories/woman-novel-gene-mutation-lives-almost-pain-free

    23 Sep 2019: Jo Cameron, a woman living in Scotland, can feel virtually no pain due to a mutation in a gene that was identified for the first time by a UCL-led team.

    Jo Cameron, a woman living in Scotland, can feel virtually no pain due to a mutation in a gene that was identified for the first time by a UCL-led team.

  9. UCL co-creates app that will improve newborn care globally | Made at…

    https://www.ucl.ac.uk/made-at-ucl/stories/ucl-co-creates-app-will-improve-newborn-care-globally

    23 Sep 2019: Around 2.5 million children die annually in their first month of life. To address this, UCL co-created Neotree – an app for all healthcare workers, producing a suggested diagnosis and management plan according to national neonatal guidelines.

    Around 2.5 million children die annually in their first month of life. To address this, UCL co-created Neotree – an app for all healthcare workers, producing a suggested diagnosis and management plan according to national neonatal guidelines.

  10. Pioneering gene therapies could mean a cure for haemophilia | Made at …

    https://www.ucl.ac.uk/made-at-ucl/stories/pioneering-gene-therapies-could-mean-cure-haemophilia

    13 Sep 2019: UCL researchers are behind the first successful gene therapy trial to treat haemophilia that will not only mean a one-off treatment but also provide hope for a range of monogenetic disorders that currently lack effective treatment.

    UCL researchers are behind the first successful gene therapy trial to treat haemophilia that will not only mean a one-off treatment but also provide hope for a range of monogenetic disorders that currently lack effective treatment.

Pagination

Refine

Subjects